| Yearly Results of Gland Pharma (in Rs. Cr.) |
Mar '22 |
Mar '21 |
Mar '20 |
Mar '19 |
Mar '18 |
|
| Net Sales/Income from operations |
4,400.71 |
3,462.88 |
2,571.78 |
1,993.15 |
1,580.07 |
|
| Other Operating Income |
-- |
-- |
61.46 |
51.06 |
39.88 |
|
| Total Income From Operations |
4,400.71 |
3,462.88 |
2,633.24 |
2,044.20 |
1,619.94 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
2,046.86 |
1,749.16 |
1,090.25 |
954.89 |
718.30 |
|
| Purchase of Traded Goods |
25.67 |
16.20 |
18.67 |
16.28 |
9.12 |
|
| Increase/Decrease in Stocks |
36.69 |
-273.49 |
-6.90 |
-114.15 |
-66.67 |
|
| Power & Fuel |
95.05 |
74.59 |
-- |
-- |
-- |
|
| Employees Cost |
338.57 |
311.36 |
277.66 |
222.95 |
179.08 |
|
| Depreciation |
110.30 |
98.78 |
94.59 |
81.96 |
78.21 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
347.23 |
282.79 |
298.09 |
257.92 |
245.00 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
1,400.34 |
1,203.49 |
860.88 |
624.35 |
456.90 |
|
| Other Income |
223.94 |
134.78 |
139.17 |
85.56 |
48.79 |
|
| P/L Before Int., Excpt. Items & Tax |
1,624.28 |
1,338.26 |
1,000.05 |
709.92 |
505.69 |
|
| Interest |
5.24 |
3.41 |
7.18 |
3.56 |
4.13 |
|
| P/L Before Exceptional Items & Tax |
1,619.04 |
1,334.85 |
992.87 |
706.36 |
501.56 |
|
| Exceptional Items |
-- |
-- |
-- |
-20.00 |
-- |
|
| P/L Before Tax |
1,619.04 |
1,334.85 |
992.87 |
686.36 |
501.56 |
|
| Tax |
406.89 |
337.85 |
220.01 |
234.45 |
180.45 |
|
| P/L After Tax from Ordinary Activities |
1,212.16 |
997.01 |
772.86 |
451.91 |
321.11 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
1,212.16 |
997.01 |
772.86 |
451.91 |
321.11 |
|
| Equity Share Capital |
16.43 |
16.36 |
15.50 |
15.50 |
15.50 |
|
| Reserves Excluding Revaluation Reserves |
7,141.72 |
5,886.93 |
3,630.74 |
2,846.62 |
2,394.93 |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
73.84 |
63.07 |
49.88 |
29.16 |
211.75 |
|
| Diluted EPS |
73.67 |
62.99 |
49.88 |
29.16 |
207.24 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
73.84 |
63.07 |
49.88 |
29.16 |
211.75 |
|
| Diluted EPS. |
73.67 |
62.99 |
49.88 |
29.16 |
207.24 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
